Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.441
-0.022 (-4.75%)
At close: Jan 17, 2025, 4:00 PM
0.440
-0.001 (-0.23%)
After-hours: Jan 17, 2025, 5:25 PM EST
Turnstone Biologics Employees
Turnstone Biologics had 80 employees as of December 31, 2023. The number of employees decreased by 28 or -25.93% compared to the previous year.
Employees
80
Change (1Y)
-28
Growth (1Y)
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$930,188
Market Cap
10.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 80 | -28 | -25.93% |
| Dec 31, 2022 | 108 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
TSBX News
- 2 months ago - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 5 months ago - Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study - Benzinga
- 5 months ago - Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - GlobeNewsWire
- 9 months ago - Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 9 months ago - Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire
- 9 months ago - Turnstone Biologics Appoints William Waddill to its Board of Directors - GlobeNewsWire
- 10 months ago - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights - GlobeNewsWire